In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.
Publication
, Journal Article
Sen, S; Newby, LK
Published in: Ann Intern Med
June 16, 2020
Solomon SD, Vaduganathan M, Claggett BL, et al. Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation. 2020;141:352-61. 31736342.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
June 16, 2020
Volume
172
Issue
12
Start / End Page
JC65
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Stroke Volume
- Humans
- Hospitalization
- Heart Failure
- General & Internal Medicine
- Drug Combinations
- Biphenyl Compounds
- Angiotensin Receptor Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
Sen, S., & Newby, L. K. (2020). In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization. Ann Intern Med, 172(12), JC65. https://doi.org/10.7326/ACPJ202006160-065
Sen, Sounok, and L Kristin Newby. “In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.” Ann Intern Med 172, no. 12 (June 16, 2020): JC65. https://doi.org/10.7326/ACPJ202006160-065.
Sen S, Newby LK. In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization. Ann Intern Med. 2020 Jun 16;172(12):JC65.
Sen, Sounok, and L. Kristin Newby. “In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.” Ann Intern Med, vol. 172, no. 12, June 2020, p. JC65. Pubmed, doi:10.7326/ACPJ202006160-065.
Sen S, Newby LK. In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization. Ann Intern Med. 2020 Jun 16;172(12):JC65.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
June 16, 2020
Volume
172
Issue
12
Start / End Page
JC65
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Stroke Volume
- Humans
- Hospitalization
- Heart Failure
- General & Internal Medicine
- Drug Combinations
- Biphenyl Compounds
- Angiotensin Receptor Antagonists